Literature DB >> 687504

The effects of indomethacin on arachidonic acid and prostaglandins e2 and f2alpha levels in human skin 24 h after u.v.B and u.v.C irradiation.

A K Black, M W Greaves, C N Hensby, N A Plummer, A P Warin.   

Abstract

1 Clinically normal human abdominal skin was irradiated with either three times its minimal erythema dose (MED) of ultraviolet B (u.v.B) or six MEDs of ultraviolet C (u.v.C) radiation. In both instances erythema was maximal at 24 h. 2 Exudate was recovered by a suction bulla technique from normal and irradiated skin at 24 h after irradiation. 3 Arachidonic acid, prostaglandins E2 and FSalpha, as measured by GC--MS, were significantly elevated at 24 h. Radioimmunoassay also showed increased PGF2alpha-like concentrations. 4 Oral indomethacin only partially reduced the erythema resulting from both types of radiation but totally suppressed the elevation of PGE 2 and F2alpha concentrations. 5 Topical indomethacin also suppressed u.v.B-induced increases in prostaglandins E2 and F2alpha. Unexpectedly, the vehicle alone produced a similar suppressive effect on prostaglandins although erythema appeared unaltered. 6 Most of the arachidonic acid metabolized by indomethacin-sensitive pathways is not converted to prostaglandins E2 and F2alpha in human skin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687504      PMCID: PMC1429458          DOI: 10.1111/j.1365-2125.1978.tb04595.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Dichotomy in response to indomethacin in UV-C and UV-B induced ultraviolet light inflammation.

Authors:  W H Eaglstein; A R Marsico
Journal:  J Invest Dermatol       Date:  1975-08       Impact factor: 8.551

2.  Vascular changes in human skin after ultraviolet irradiation.

Authors:  C A Ramsay; A V Challoner
Journal:  Br J Dermatol       Date:  1976-05       Impact factor: 9.302

3.  The development of antisera to prostaglandins B2 and F2alpha and their analysis using solid-phase and double antibody radioimmunoassay methods.

Authors:  K K Dighe; H A Emslie; L K Henderson; L Simon
Journal:  Br J Pharmacol       Date:  1975-12       Impact factor: 8.739

4.  A new method for recovery of exudates from normal and inflamed human skin.

Authors:  A K Black; M W Greaves; C N Hensby; N A Plummer; R A Eady
Journal:  Clin Exp Dermatol       Date:  1977-09       Impact factor: 3.470

5.  Topical indomethacin and sunburn.

Authors:  D S Snyder; W H Eaglstein
Journal:  Br J Dermatol       Date:  1974-01       Impact factor: 9.302

6.  Aspirin and ultraviolet light-induced erythema in man.

Authors:  W S Miller; F R Ruderman; J G Smith
Journal:  Arch Dermatol       Date:  1967-04

7.  Pharmacological studies in inflammation due to exposure to ultraviolet radiation.

Authors:  J Sondergaard; M W Greaves
Journal:  J Pathol       Date:  1970-06       Impact factor: 7.996

8.  Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.

Authors:  C M Gruber; A S Ridolfo; R Nickander; W M Mikulaschek
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

9.  Increased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290- 320 nm).

Authors:  A K Black; M W Greaves; C N Hensby; N A Plummer
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

10.  Irradiation of human skin by short wavelength ultraviolet radiation (100--290 nm) (u.v.C): increased concentrations of arachidonic acid and prostaglandines E2 and F2alpha.

Authors:  R D Camp; M W Greaves; C N Hensby; N A Plummer; A P Warin
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

View more
  12 in total

1.  Arachidonic acid and prostanoids in suction blister fluid from psoriatic lesions and unaffected skin.

Authors:  C Hensby; L Juhlin; A Civier; B Berne; G Michaëlsson; C Vahlqvist
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

2.  The quantitative analysis of 6-keto PGF1 alpha in biological fluids by stable isotope dilution utilizing gas chromatography-mass spectrometry (GC-MS) [proceedings].

Authors:  P Barnes; C T Dollery; C N Hensby
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

3.  Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.

Authors:  E Wong; R M Barr; F M Cunningham; K Mistry; P M Woollard; A I Mallet; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

4.  Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema.

Authors:  A P Pentland; M Mahoney; S C Jacobs; M J Holtzman
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

5.  The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation.

Authors:  A Kobza Black; M W Greaves; C N Hensby
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

6.  The effects of topical corticosteroids on delayed pressure urticaria.

Authors:  R J Barlow; D M Macdonald; A K Black; M W Greaves
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

7.  The catabolism of prostaglandins by rat skin.

Authors:  R Camp; M W Greaves
Journal:  Biochem J       Date:  1980-01-15       Impact factor: 3.857

8.  Time course changes in levels of arachidonic acid and prostaglandins D2, E2, F2 alpha in human skin following ultraviolet B irradiation.

Authors:  A K Black; N Fincham; M W Greaves; C N Hensby
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

9.  Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine.

Authors:  B Fjellner; O Hägermark
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

10.  Lipoxygenase products of arachidonic acid in human inflamed skin.

Authors:  A K Black; R M Barr; E Wong; S Brain; M W Greaves; R Dickinson; B Shroot; C N Hensby
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.